Russian medical facilities have received drug products for protection against tetanus, diphtheria, hepatitis B and tuberculosis

Photo: Nacimbio holding

Nacimbio holding has completed the first vaccine supply stage in 2025 for the National Immunization Schedule. In January, Russian regions received drug products for protection against tetanus, diphtheria, hepatitis B and tuberculosis. The first delivery batch included 2 million vaccine doses. 

All supplied vaccines are fully made by NPO Microgen branches and other Russian factories — from active substance preparation to commercialization. This approach ensures execution of the National Immunization Schedule independently of foreign suppliers. 

The National Immunization Schedule establishes timelines and procedure for national vaccination. In Russia it includes vaccination against 12 diseases — measles, rubella, parotitis, pertussis, influenza, tuberculosis, hepatitis B, diphtheria, tetanus, poliomyelitis, haemophilus influenzae type b and pneumococcal disease. Planned immunization in accordance with the National Immunization Schedule ensures population immunity and prevents epidemic spreading.